Skip to content
Biomeme Labs
Labs

Test before you start. See what moved after.

If you use peptides, often with a clinician's guidance, a sample before you start and another after shows which parts of your inflammation system moved. It shows what changed, never whether a peptide worked or is safe.

How you feel is hard to compare.
Your readings aren't.

Most people judge a new routine by how they feel, and feelings are hard to compare from one month to the next. The Inflammation Compass reads which genes your immune cells are using, from the signals that start a response to the signals that end it, so you have something to compare.

  1. Before you start

    Your first sample starts your personal baseline: where each of your six readings sits against people measured the same way.

  2. After a few weeks

    A second sample gives you a comparison. Your report shows which readings moved, by how much, and which stayed about the same.

  3. Over several samples

    From the third sample, a trend begins to show, and you can start to tell a passing shift from a pattern, including after you pause or stop.

Already started?

Your first sample becomes your baseline from that point on. It can’t show what changed before you gave it, so it won’t tell you what a peptide has already done. It will show where you stand now, and later samples will show what moves from here, including after you change, pause, or add something.

Six readings,
each with a job.

Your report has six readings: three for the signals that start a response and three for the signals that end it. Each groups pathways from one broad part of the inflammation system, and each pathway has a job, such as raising the alarm or clearing up afterward. Your immune cell mix is estimated from the same sample.

Activation starts a response
Activation Level, Targeted Defense, and Where the Fast Response Is Working.
Resolution ends it
Resolution Level, Regulatory Cells & Repair Signals, and Clean-up & Rebuilding.

The goal is an inflammation response that fits the situation and finishes its work, not simply low inflammation. That is why your report shows results as positions against a reference group, never as a score to push down.

See what the report includes

Common peptides,
and what has been studied.

Much of the research on these peptides is in cells and animals, not people. The Inflammation Compass doesn’t measure peptide levels or local tissue repair; it reads the gene activity of your circulating immune cells.

  • BPC-157

    Studied in animal models of gut and tendon injury. There are no published human trials.

  • TB-500

    A fragment of thymosin beta-4, studied preclinically for tissue repair and cell migration.

  • MOTS-c

    A peptide encoded in mitochondria, studied mainly in animal models of metabolic regulation.

  • Epitalon

    A synthetic peptide studied in cell and animal models of cellular aging and pineal function.

What it
can't tell you.

The Inflammation Compass shows what changed and by how much. It can’t show why, because many things move these readings, and it doesn’t show whether a peptide, supplement or other change worked or is safe. It doesn’t diagnose, rule out or predict any disease.

What a change means is for you, and your clinician if you have one, to weigh. If a result worries you, talk it through with a clinician before changing what you’re doing.

Start with your baseline.

Give your first sample before you start a new routine, or now if you already have.

$389 per test, or $365 each when you order 4 or more. Mobile phlebotomy and shipping included.